3rd Quarter - Report — AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN (2010)

Firm

AMERICAN CLINICAL LABORATORY ASSN

Client

AMERICAN CLINICAL LABORATORY ASSN

Income

—

Expenses

$210,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 111-148: health reform law implementation issues; HR 4213, American Jobs and Closing Tax Loopholes Act of 2010: health care provisions including physican payment; HR 5440, Genomics and Personalized Medicine Act of 2010; FDA oversight of laboratory developed tests; physician self-referral of anatomic pathology services; medical device taxation; physician signature requirement

Lobbyist	Covered position, as disclosed
JASON DUBOIS	Vice President, Government Relations
JO ANNE GLISSON	Senior Vice President
CHARLENE MACDONALD	Vice President, Government Relations
ALAN MERTZ	President
DAVID ALAN MONGILLO	Vice President, Policy and Medical Affairs

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 4213 (111th), H.R. 5440 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.